You are here

  • Home
  • Archive
  • Volume 71, Issue 10
  • Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis

Authors

  1. Correspondence to Juha Risteli, Institute of Diagnostics, Department of Clinical Chemistry, University of Oulu, PO Box 5000, FI-90014 Oulu, Finland; juha.risteli{at}oulu.fi
View Full Text

Citation

Koivula M, Heliövaara M, Rissanen H, et al
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis
Annals of the Rheumatic Diseases 2012;71:1666-1670.

Publication history

  • Received September 30, 2011
  • Accepted January 31, 2012
  • First published March 14, 2012.
Online issue publication 
September 10, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions